Clinical program tracker
Representative EV therapeutic trials with registry links. Filter by delivery route and practicality tier when evaluating new deals.
| Program | Sponsor | Indication | Route | Phase | Status | Practicality | Sources |
|---|---|---|---|---|---|---|---|
| ExoFlo | Direct Biologics | Moderate-to-severe ARDS | Intravenous | Phase 3 | Recruiting | Low-moderate | NCT05354141 |
| hMSC-Exos nebulizer | Ruijin Hospital | ARDS | Inhaled | Phase 1/2 | Completed | Moderate-low | NCT04602104 |
| AGLE-102 | Aegle Therapeutics | Recessive dystrophic epidermolysis bullosa (wounds) | Topical | Phase 1/2A | Recruiting | Moderate | NCT04173650 |
| PEP-TISSEEL | RION | Diabetic foot ulcers | Topical | Phase 2a | Enrolling complete | Moderate | NCT06319287 |
| AB126 | Aruna Bio | Acute ischemic stroke (post-thrombectomy) | Intravenous | Phase 1b/2a | IND cleared | Moderate-low |